Showing results (11-20 of 74) with videos related to

Sort By:
Pageof 8
Journal of Behavioral Medicine|January 20, 2023
Evaluating Objective Metrics of habit strength for taking medicationsL Alison Phillips, Antoine Pironet, Bernard Vrijens
Annual Review of Pharmacology and Toxicology|September 28, 2011
Adherence to medications: insights arising from studies on the unreliable link between prescribed and actual drug dosing historiesTerrence F Blaschke, Lars Osterberg, Bernard Vrijens, et al.
Biostatistics (Oxford, England)|September 1, 2010
A structural mean model to allow for noncompliance in a randomized trial comparing 2 active treatmentsKrista Fischer, Els Goetghebeur, Bernard Vrijens, et al.
Journal of Hypertension|March 21, 2009
Impact of supportive measures on drug adherence in patients with essential hypertension treated with valsartan: the randomized, open-label, parallel group study VALIDATERainer Düsing, Renate Handrock, Sven Klebs, et al.
BMJ (Clinical Research Ed.)|May 16, 2008
Adherence to prescribed antihypertensive drug treatments: longitudinal study of electronically compiled dosing historiesBernard Vrijens, Gäbor Vincze, Paulus Kristanto, et al.
Clinical Trials (London, England)|September 10, 2009
Linear and loglinear structural mean models to evaluate the benefits of an on-demand dosing regimenLaetitia Comté, Stijn Vansteelandt, Eric Tousset, et al.
British Journal of Clinical Pharmacology|February 9, 2020
How the EMERGE guideline on medication adherence can improve the quality of clinical trialsLina Eliasson, Sarah Clifford, Amy Mulick, et al.
Journal of Pharmacokinetics and Pharmacodynamics|May 15, 2007
Estimation of the comparative therapeutic superiority of QD and BID dosing regimens, based on integrated analysis of dosing history data and pharmacokineticsLaetitia Comté, Bernard Vrijens, Eric Tousset, et al.
Pharmacoepidemiology and Drug Safety|December 13, 2005
Effect of intervention through a pharmaceutical care program on patient adherence with prescribed once-daily atorvastatinBernard Vrijens, Ann Belmans, Katelijne Matthys, et al.
Trials|April 16, 2026
Guideline for the Measurement, Analysis and Reporting of Medication Adherence during the Run-in phase of clinical trials (MARMAR)Non Davies, Bernard Vrijens, Daniel F B Wright, et al.
Pageof 8